Konakion


Indications and Reactions:

Role Indications Reactions
Secondary
Cardiac Failure 9.4%
Hypokalaemia 9.4%
Product Used For Unknown Indication 9.2%
Pain 8.7%
Infection Prophylaxis 7.0%
Sepsis 5.7%
Thrombosis Prophylaxis 5.0%
Constipation 4.8%
Atrial Fibrillation 3.9%
Electrolyte Substitution Therapy 3.9%
Pyrexia 3.9%
Chronic Obstructive Pulmonary Disease 3.7%
Infection 3.7%
Supplementation Therapy 3.5%
Prophylaxis Against Gastrointestinal Ulcer 3.3%
Delirium 3.1%
Nausea 3.1%
Unevaluable Event 3.1%
Hypertension 2.8%
Parenteral Nutrition 2.8%
Toxic Epidermal Necrolysis 32.8%
International Normalised Ratio Increased 13.1%
Thrombocytopenia 9.8%
Renal Failure Acute 8.2%
Stevens-johnson Syndrome 6.6%
Tubulointerstitial Nephritis 4.9%
Drug Ineffective 3.3%
Haematoma 3.3%
Staphylococcal Sepsis 3.3%
Cardiovascular Disorder 1.6%
Delirium 1.6%
Diarrhoea 1.6%
Injection Site Erythema 1.6%
Ischaemic Stroke 1.6%
Pseudomembranous Colitis 1.6%
Stem Cell Transplant 1.6%
Thrombotic Thrombocytopenic Purpura 1.6%
Viral Infection 1.6%
Concomitant
Product Used For Unknown Indication 26.5%
Drug Use For Unknown Indication 21.6%
Prophylaxis 7.5%
Pain 6.7%
Multiple Myeloma 6.2%
Hypertension 5.3%
Acute Myeloid Leukaemia 3.8%
Thrombosis Prophylaxis 3.3%
Sepsis 2.9%
Infection Prophylaxis 1.9%
Metastatic Renal Cell Carcinoma 1.8%
Anaesthesia 1.7%
Aspergillosis 1.6%
Hypokalaemia 1.4%
Nausea 1.4%
Chronic Obstructive Pulmonary Disease 1.4%
Atrial Fibrillation 1.3%
Pyrexia 1.3%
Epilepsy 1.3%
Cardiac Failure 1.2%
Respiratory Failure 14.0%
Toxic Epidermal Necrolysis 9.5%
Sepsis 7.3%
Thrombocytopenia 7.3%
Renal Failure Acute 6.1%
Rhabdomyolysis 5.6%
White Blood Cell Count Decreased 5.6%
Renal Failure 5.0%
Stevens-johnson Syndrome 5.0%
Inappropriate Antidiuretic Hormone Secretion 4.5%
Septic Shock 3.9%
Vomiting 3.9%
Nausea 3.4%
Prothrombin Time Prolonged 3.4%
Hepatitis Acute 2.8%
Pyrexia 2.8%
Shock 2.8%
Vanishing Bile Duct Syndrome 2.8%
Arrhythmia 2.2%
Clostridium Difficile Colitis 2.2%

Drug Data